SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-196205
Filing Date
2012-04-30
Accepted
2012-04-30 16:34:28
Documents
6
Effectiveness Date
2012-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d317548ddefa14a.htm DEFA14A 57968
2 GRAPHIC g317548notice_pg01.jpg GRAPHIC 1124
3 GRAPHIC g317548notice_pg02a.jpg GRAPHIC 2957
4 GRAPHIC g317548notice_pg02b.jpg GRAPHIC 1116
5 GRAPHIC g317548notice_pg03.jpg GRAPHIC 1104
6 GRAPHIC g317548notice_pg04.jpg GRAPHIC 1118
  Complete submission text file 0001193125-12-196205.txt   69968
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21696 | Film No.: 12795557
SIC: 2836 Biological Products, (No Diagnostic Substances)